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Introduction
In the course of the maturation of spliceosomal U small nuclear 
RNP (snRNP) in metazoa, U small nuclear RNA (snRNA) pre-
cursors are initially exported from the nucleus after transcription 
(Mattaj, 1988; for review see Will and Luhrmann, 2001). This ex-
port is mediated by CRM1, a member of the importin- family 
(Fornerod et al., 1997; Fukuda et al., 1997; Ossareh-Nazari et al., 
1997; Stade et al., 1997). CRM1, known as the export receptor 
for proteins carrying a leucine-rich nuclear export signal (NES; 
Fischer et al., 1995; Wen et al., 1995), binds directly to NES but 
indirectly to U snRNA.
Two adaptor proteins are involved in the interaction be-
tween CRM1 and U snRNAs. One is the heterodimeric cap-
binding complex (CBC), which binds specifically to the essential 
export signal of U snRNA, the m
7G-cap structure (Ohno et al., 
1990; Izaurralde et al., 1994, 1995; Kataoka et al., 1995). The 
other adaptor is a phosphorylated protein termed phosphorylated 
adaptor for RNA export (PHAX) that acts as a bridge between 
CRM1 and the CBC–RNA complex (Ohno et al., 2000). PHAX 
has a leucine-rich NES to which CRM1 binds cooperatively with 
RanGTP. The NES sequence in PHAX is functional only when 
PHAX is properly phosphorylated (Ohno et al., 2000). In this 
way, these five proteins and a U snRNA molecule assemble into 
the  export  complex  in  the  nucleus,  and  this  complex  subse-
quently moves to the cytoplasm. Thus, the composition of the   
U snRNA export complex is relatively well characterized. How-
ever, very little information is available regarding when and 
where these factors associate with U snRNA precursors in 
the nucleus.
After being exported to the cytoplasm, U snRNAs asso-
ciate with a group of Sm proteins with the help of molecular 
chaperons termed the survival of motor neurons complex (for re-
view see Kolb et al., 2007; Chari et al., 2009). The m
7G-cap 
structure of the U snRNAs is subsequently trimethylated, and 
the trimethylated cap is recognized by snurportin-1 (Huber   
et al., 1998). The RNA-bound Sm proteins and snurportin-1 con-
stitute a bipartite nuclear import signal that directs the nuclear 
import of U snRNPs by importin-. Before or during the nuclear 
import process, a few nucleotides at the 3 terminus are trimmed 
(for review see Will and Luhrmann, 2001). Once imported into 
the nucleus, the U snRNPs associate with Cajal bodies (CBs), 
the site for RNA modifications such as 2’-O-ribose-methylation 
and pseudouridylation (Jady et al., 2003; for review see Cioce 
and Lamond, 2005). Specific RNP assembly is also thought to   
occur within CBs, including the assembly of the 17S U2 snRNP 
(Nesic et al., 2004) and of tri-snRNPs after each round of splicing 
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Figure 1.  Transport of Cy3-labeled U1Sm RNA microinjected into the Xenopus oocyte nuclei. (A) In vitro–transcribed Cy3-labeled m
7G-capped U1Sm 
RNA was microinjected into Xenopus oocyte nuclei that had been cytoplasmically preinjected with Cy5-labeled U7 RNA as a marker of Cajal Bodies 12 h 
earlier. The nuclei were manually isolated under mineral oil at 1 (left), 3 (middle), and 6 h (right) after injection. The nuclei were observed by fluorescent 
microscopy as described in Materials and methods. Red, Cy3-U1Sm; yellow, Cy5-U7. The arrows and the dotted lines represent Cajal bodies and the 
nuclear envelope, respectively. Bars, 20 µm. (B) A mixture of in vitro–transcribed Cy3-labeled U1Sm and FITC-labeled U6ss RNAs was microinjected 
into the Xenopus oocyte nuclei. RNA was extracted from nuclear (N) and cytoplasmic (C) fractions 1, 3, and 6 h after microinjection and analyzed by 8% 
denaturating PAGE followed by Typhoon scan. (C) Xenopus oocytes were fractionated into Nsup, Nppt, and cyctoplasmic fractions as described in Materi-
als and methods. Western blotting was performed with total oocyte (total), Nsup, Nppt, and cytoplasmic fractions using antibodies against coilin, PHAX, 
and U2B”. Each lane was loaded with materials from 2.5 oocytes. (D) Northern blotting was performed with RNA prepared from total, Nsup, Nppt, and 605 Novel role for Cajal bodies in U snRNA export • Suzuki et al.
(Schaffert et al., 2004; Stanek and Neugebauer, 2004; for review 
see Stanek and Neugebauer, 2006). All these events represent 
critical steps in the making of a fully functional snRNP. Finally, 
snRNPs are recruited to nuclear speckles, where the final stages 
of maturation like further packaging may occur (for review see 
Patel and Bellini, 2008).
Thus, the role of CBs in the maturation of U snRNPs,   
after their reimport into the nucleus, is relatively clear. How-
ever, the following several studies have suggested that CBs also 
have roles in the processes before the initial nuclear export of   
U snRNA precursors. First, U snRNA genes are often found   
adjacent to CBs (Frey and Matera, 1995; Smith et al., 1995).   
The U snRNA transcription factor proximal sequence element-
binding transcription factor is enriched in CBs (Schul et al., 
1998), and active transcription of U snRNA genes frequently 
occurs in association with CBs (Jacobs et al., 1999; Frey and   
Matera, 2001; Dundr et al., 2007). It was also shown that the   
nascent U snRNA transcripts themselves mediate the association 
between U snRNA genes and CBs (Frey et al., 1999; Frey and 
Matera, 2001). Second, U snRNA precursors before nuclear ex-
port can be found in CBs. U snRNA precursors before 3 end 
trimming were detected in CBs of HeLa cells by RNA FISH 
(Smith and Lawrence, 2000). Also, it was serendipitously 
observed in Xenopus laevis oocytes that a fraction of micro-
injected U2 snRNA localized to CBs before export (Yu et al., 
2001). Third, both PHAX and CRM1, critical U snRNA export 
factors, are enriched in CBs (Frey and Matera, 2001; Massenet 
et al., 2002; Boulon et al., 2004; Renvoise et al., 2009). Collec-
tively, these studies suggest that transcribed U snRNA precur-
sors may first transit through CBs before their passage through 
the nuclear pore complexes (NPCs; for review see Matera et al., 
2007). However, such a scenario is yet to be supported by strong 
experimental evidence.
In  this  study,  in  vitro–transcribed  U  snRNA  precursors 
were microinjected into the nuclei of Xenopus oocytes to exam-
ine whether they transit through CBs before their nuclear export. 
The signals from the injected U snRNAs temporarily accumu-
lated in CBs soon after the microinjection and gradually de-
creased as the RNA export proceeded. Inhibition of PHAX 
activity by either an anti-PHAX antibody or a dominant-negative 
PHAX mutant led to inhibition of U snRNA export and simulta-
neously enhanced the accumulation of U snRNAs in CBs. In con-
trast, inhibition of CRM1 activity by excess NES sequences or 
inhibition of the function of NPCs by WGA resulted in the accu-
mulation of U snRNAs in the nucleoplasm but not in CBs. More-
over, a combination of the inhibitors confirmed that U snRNAs 
transit through CBs before passing through NPCs and that proper 
binding of PHAX but not CRM1 to U snRNAs is required for the 
efficient exit of U snRNAs from CBs. From these results, it is 
suggested that one function of CBs is to check whether U snRNA 
precursors are properly bound by PHAX.
Results
Injected U snRNA precursors associate 
with CBs before nuclear export
To examine whether U snRNA precursors transit through CBs 
before their nuclear export, an attempt was made to visualize the 
distribution of the precursors in Xenopus oocyte nuclei. Cy3-
  labeled U1Sm RNA, which has mutations in the Sm-binding site 
and therefore cannot be reimported into the nucleus, was micro-
injected into the nuclei of Xenopus oocytes. After incubation for 
certain periods, the nuclei were manually isolated in a mineral oil 
and observed under a fluorescence microscope as described pre-
viously (Patel et al., 2008). After 1 h of incubation, the signal of 
U1Sm RNA was highly enriched in specific dots with a rela-
tively homogeneous nucleoplasmic signal (Fig. 1 A, top left).
To examine whether these specific dots represented CBs, 
Cy5-labeled U7 snRNAs, known to stably localize in CBs after 
microinjection (Wu et al., 1996), were preinjected as a marker. 
In fact, the two signals merged (Fig. 1 A, left), indicating that 
the injected U1Sm was concentrated in CBs at this time point. 
The U1Sm RNA signal was not enriched in other nuclear   
domains such as chromosomes, nucleoli, nuclear speckles   
(B snurposomes), or the nuclear envelope (Fig. 1 A and not   
depicted). At later time points (3 and 6 h after microinjection),   
the Cy3 signal of U1Sm RNA gradually decreased in both CBs 
and the nucleoplasm (Fig. 1 A, middle and right).
To confirm that the decrease in Cy3 signals was due not to 
RNA degradation but to U snRNA export, the stability and export 
kinetics of the injected U1SmRNA were monitored in a parallel 
experiment. RNA was extracted from nuclear and cytoplasmic 
fractions at each time point after microinjection and analyzed by 
gel electrophoresis followed by visualization of the fluorescent 
RNA bands (Fig. 1 B). The stability and export kinetics of the in-
jected Cy3-U1Sm RNA were similar to those of the 
32P-labeled 
U1Sm RNA (unpublished data). The total U1Sm RNA sig-
nal was fairly constant, indicating that the injected U1Sm was 
highly stable in Xenopus oocytes. Moreover, the decrease in Cy3 
signals in Fig. 1 A was well concomitant with the extent of RNA 
export. These results are consistent with the idea that U1Sm 
RNAs move to CBs before their nuclear export.
To obtain more quantitative information about the distribu-
tion of the injected U snRNA precursors, we fractionated the nuclei 
of Xenopus oocytes into insoluble (Nppt) and soluble (Nsup) frac-
tions as described previously (Wu et al., 1996). The Nppt fraction 
contains nuclear organelles such as chromatins, CBs, nucleoli, and 
nuclear speckles, etc., whereas Nsup contains soluble materials of 
the nucleoplasm (Wu et al., 1996). Western blotting showed that 
coilin, a marker of CBs, and U2B”, a protein component of U2 
snRNP found in both CBs and nuclear speckles, were mainly de-
tected in the Nppt fraction (Fig. 1 C). Similarly, Northern blotting 
showed that U3 small nucleolar RNA (snoRNA), which is found 
cytoplasmic fractions using probes against U3 snoRNA and 5.8S rRNA. Each lane was loaded with RNA from 2.5 oocytes. nt, nucleotide. (E) A mixture of 
32P-labeled m
7G-capped U1Sm, m
7G-capped U5Sm, U6ss, and initiator methionyl tRNA was injected into the nucleus of Xenopus oocytes. RNA was 
extracted from Nsup, Nppt, and cytoplasmic fractions immediately at 0 (lanes 1–3) 1 (lanes 4–6), 2 (lanes 7–9), 3 (lanes 10–12), and 6 h (lanes 13–15) 
after microinjection and analyzed by 8% denaturating PAGE followed by autoradiography. (F and G) Quantification of the radioactivity of U1 and U5 
bands in E, respectively. Yellow, C fraction; red, Nsup fraction; blue, Nppt fraction. Black lines indicate that intervening lanes have been spliced out.
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U snRNAs also accumulated in the Nppt fraction, which was 
nearly identical to the effect of the antibody alone (Fig. 2, A [lanes 
16–21], C, and D [quantification]). These results confirmed that 
the PHAX antibody inhibited an earlier transport step than WGA. 
The accumulation of U snRNAs in CBs in the presence of WGA 
and the anti-PHAX antibody was confirmed by injecting Cy3-
U1Sm and visualizing the Cy3 signals (Fig. 2 E).
Next, we examined the effects of coinjection of various 
PHAX mutant proteins (Fig. 3 A), some of which were already 
shown to act in a dominant-negative fashion on U snRNA ex-
port (Ohno et al., 2000; Segref et al., 2001; Kitao et al., 2008). 
Coinjection of the PHAX CD mutant, having a small deletion in 
the RNA-binding domain (Fig. 3 A) and therefore unable to bind 
RNA (Segref et al., 2001), had no effect on the distribution of the 
U snRNAs (Fig. 3 B, lanes 7–9). Two other mutants, NES and 
ST2, which had mutations in the NES and critical phosphoryla-
tion sites, respectively (Fig. 3 A), are both known to be defective 
in binding to CRM1 (Ohno et al., 2000; Kitao et al., 2008). Micro-
injection of the NES or ST2 mutant protein inhibited U snRNA 
export as demonstrated previously (Ohno et al., 2000; Kitao 
et al., 2008), but the injected U snRNAs accumulated in the   
nucleoplasm (Nsup; Fig. 3 B, lanes 13–18). Another mutant protein, 
PHAX N lacking the N-terminal 175 amino acid residues, can 
still bind to RNA but not stably to CBC (similar to the N4 mutant 
in Segref et al., 2001). This protein was not previously tested   
in microinjection experiments. Microinjection of PHAX N   
also inhibited U snRNA export, but in this case, the injected   
U snRNAs strongly accumulated in the insoluble Nppt fraction   
(Fig. 3 B, lanes 10–12). Usage of both PHAX N and WGA also 
resulted in enhanced accumulation of U snRNAs in the Nppt frac-
tion (Fig. 3, B [lanes 22–24], C, and D). The longer the incubation, 
the more U snRNA accumulated in the Nppt fraction (Fig. 3 E, 
lanes 10–18). Note that the majority of the injected U snRNAs 
were found in the Nppt fraction at 3 h (Fig. 3 E, lane 17). Visual-
ization of the U snRNAs confirmed that they in fact accumulated 
in CBs (Fig. 3 F). These results suggested that the N mutant 
protein markedly slows down the exit of U snRNAs from CBs and 
confirmed that proper binding of PHAX is required for U snRNAs 
to exit CBs and that the transit through CBs is part of the major 
route of U snRNA export.
Binding of CRM1 is not required for  
U snRNAs to exit CBs
The results suggested that CBs check the binding of PHAX to   
U snRNAs. If PHAX is not bound properly, the RNA cannot exit 
CBs. However, CRM1, another U snRNA export factor, was also 
shown to be enriched in CBs (Boulon et al., 2004; Renvoise et al., 
2009). To examine whether the binding of CRM1 is required for 
the exit of U snRNAs from CBs, we used BSA-NES, a conjugate 
of NES peptides coupled to BSA, which saturates CRM1 export 
(Fischer et al., 1995). Microinjection of BSA-NES but not a mu-
tant version (BSAmut) inhibited U snRNA export, as described 
previously (Fornerod et al., 1997; Ohno et al., 2000), and   
U snRNAs accumulated in the nucleoplasm (Nsup) but not in   
Nppt (Fig. 4 A, compare lanes 22–24 with lanes 13–15). In con-
trast,  coinjection  of  both  BSA-NES  and  PHAXN  resulted   
in enhanced RNA accumulation in Nppt, i.e., in CBs (Fig. 4, A 
mainly in nucleoli and partially in CBs, was also detected in the 
Nppt fraction, whereas 5.8S rRNA was mainly detected in the   
cytoplasmic fraction (Fig. 1 D). PHAX, the key U snRNA export 
mediator, was detected mainly in the Nsup fraction and partially 
in the Nppt and C fractions (Fig. 1 C), reminiscent of the fact that 
PHAX is found in CBs as well as the nucleoplasm in mammalian 
cell nuclei (Frey and Matera, 2001; Massenet et al., 2002; Boulon 
et al., 2004; Renvoise et al., 2009).
A mixture of 
32P-labeled RNAs containing U1Sm, U5Sm, 
U6ss,  and  initiator  methionyl  tRNA  was  microinjected  into   
the nuclei of Xenopus oocytes, and the distribution of the RNAs 
was  examined  using  the  aforementioned  fractionation  method 
(Fig. 1 E). U6ss RNA has been frequently used as a marker for 
the efficacy of nuclear microinjection because U6 RNA never 
leaves the nucleus (Vankan et al., 1990), and in addition, U6ss 
RNA has a small deletion in the single-stranded region, therefore 
being defective in nuclear migration from the cytoplasm (Hamm 
and Mattaj, 1989). U6ss RNA was consistently detected only in 
the Nsup fraction, whereas tRNA, which is rapidly exported, was 
mostly detected in the C fraction at all time points except 0 h   
(Fig. 1 E). However, both U snRNAs (U1Sm and U5Sm) were 
detected in Nppt and Nsup fractions maximally at 1 h (Fig. 1 E, 
lanes 4–6), and their signals gradually decreased as the RNA ex-
port proceeded (Fig. 1 E, lanes 7–15). Because the Nppt fraction 
contains CBs, and CBs are the only nuclear structures in which the 
injected U snRNAs are concentrated (Fig. 1 A), it is plausible that 
the signals of U snRNAs in the Nppt fraction mostly represent the 
signals in CBs. Note that the export of injected U snRNAs was 
completed within 6 h, and the injected U snRNAs were highly   
stable during the incubation. Given that 30% of the injected   
U snRNAs was found in the Nppt fraction at 1 h (Fig. 1, F and G),   
a significant fraction of the injected U snRNAs would transit 
through CBs before nuclear export.
Injected U snRNA precursors accumulate 
more strongly in CBs when PHAX activity 
is perturbed
The aforementioned results prompted us to examine the effect of 
various inhibitors of U snRNA export on the distribution of   
U snRNA in the nucleus. A mixture of 
32P-labeled RNAs contain-
ing U1Sm, U5Sm, and U6ss was microinjected into the nu-
cleus of Xenopus oocytes in the presence or absence of various 
inhibitors of U snRNA export, and the distribution of the injected 
RNAs was examined (Fig. 2). Coinjection of WGA, which binds 
NPCs and therefore inhibits the passage of many nuclear trans-
port cargoes through NPCs, strongly inhibited the export of both 
U snRNAs (Fig. 2 A, compare lanes 4–6 with lanes 7–9). Note that 
the injected U snRNAs mainly accumulated in the nucleoplasm 
(Nsup) in this case. Similarly, coinjection of an affinity-purified 
anti-PHAX antibody inhibited the export of U snRNAs (Fig. 2 A, 
lanes 13–15). However, in this case, a much higher percentage of 
U snRNAs accumulated in the Nppt fraction. In vitro gel mobility 
shift experiments revealed that this antibody inhibits the assembly 
of PHAX onto the U snRNA–CBC complex (Fig. 2 B). These re-
sults  suggested  that  proper  binding  of  PHAX  is  required  for   
U snRNAs to efficiently exit from CBs into the nucleoplasm. 
When both WGA and the anti-PHAX antibody were coinjected, 607 Novel role for Cajal bodies in U snRNA export • Suzuki et al.
RNA transport by itself, but in some cases, might not reflect the 
true situation in vivo, where U snRNAs are transcribed from their 
genes. Therefore, we microinjected the plasmid containing the 
U1Sm and U2Sm genes into the nuclei of Xenopus oocytes 
and examined the distribution of U1Sm and U2Sm RNAs 
transcribed in vivo by Northern blotting. Coinjection of the anti-
PHAX antibody or PHAX N mutant protein, in the presence of 
WGA, led to enhanced RNA signals in the Nppt fraction as com-
pared with the injection of the control IgG or other PHAX mu-
tants (Fig. 5, A–C [quantification]). These findings indicated that 
proper binding of PHAX is required for U snRNAs transcribed   
in vivo to exit CBs efficiently and supported the results of the 
RNA microinjection experiments.
[lanes 28–30], B, and C), indicating that BSA-NES blocked not 
the entry of U snRNAs into CBs but the step after the exit of   
U snRNAs from CBs, most likely the passage of RNA through 
NPCs. These results indicate that the binding of CRM1, unlike 
PHAX, is not required for U snRNA to exit CBs.
Proper binding of PHAX is required for  
in vivo–transcribed U snRNAs to exit CBs
The aforementioned results were obtained from RNA micro-
injection experiments in which RNAs transcribed in vitro were 
microinjected into the nuclei of Xenopus oocytes and therefore   
in which RNA export was not dependent on transcription in vivo. 
This  experimental  system  was  advantageous  for  focusing  on 
Figure  2.  Effect  of  anti-PHAX  antibody  on 
the  distribution  of  injected  U  snRNA  precur-
sors. (A) A mixture of 
32P-labeled m
7G-capped   
U1Sm,  m
7G-capped  U5Sm,  and  U6ss   
was injected into the nucleus of Xenopus oo-
cytes either alone (lanes 1–6) or together with   
0.42 µg/oocyte WGA (lanes 7–9), 33 ng/oocyte   
control (ctr) IgG (lanes 10–12), or anti-PHAX 
antibody  (lanes  13–15),  WGA  and  control 
IgG (lanes 16–18), or WGA and anti-PHAX 
antibody (lanes 19–21). RNA was extracted 
and analyzed as in Fig.1 E at 0 and 2 h after 
injection.  C,  cytoplasmic  fraction.  (B)  A 
32P-
labeled m
7G-capped U1Sm was incubated 
either alone (lane 1) or together with 1 µM re-
combinant CBC (lane 2), 1 µM of each recom-
binant CBC and PHAX (lane 3), or CBC and 
PHAX and affinity-purified anti-PHAX antibody 
(lane 4) for 20 min at 25°C. The samples were 
fractionated by native 6% PAGE followed by 
autoradiography. Free RNA and major com-
plexes are indicated on the right. Black lines 
indicate  that  intervening  lanes  have  been 
spliced out. (C and D) The radioactivity of the 
bands of U1Sm and U5Sm RNAs, respec-
tively, was quantified from three independent 
experiments as in A, and the ratio of the Nppt   
signal against the nuclear fraction total (Nppt +   
Nsup) signal was calculated. The means and 
standard deviations for WGA alone, WGA + 
control, IgG, and WGA + anti-PHAX antibody 
are shown. (E) The distribution of Cy3-labed 
m
7G-capped U1Sm RNA was analyzed as 
in Fig.1 A at 2 h after microinjection in the 
presence of WGA + affinity-purified anti-PHAX 
antibody  (right)  or  WGA  +  control  (control) 
IgG (left). Bars, 20 µm.JCB • VOLUME 190 • NUMBER 4 • 2010   608
the nascent U snRNA transcript, is required for this association 
(Frey and Matera, 1995, 2001; Frey et al., 1999). Thus, when 
a U snRNA gene starts transcription, it probably associates   
with a CB via a process mediated by the nascent U snRNA   
transcript that has not been released from the gene. Because   
the U snRNA–specific transcription factor proximal sequence 
element-binding transcription factor is abundant in CBs (Schul   
et al., 1998), this association should enhance the transcription 
itself. This seems to be part of the biological significance of 
this association.
Some  factor  in  CBs  should  mediate  the  association 
with the gene through interaction with the nascent U snRNA 
transcript. PHAX is a good candidate for such a factor. The cap 
Discussion
U snRNA transport from genes  
to cytoplasm
We have provided evidence that spliceosomal U snRNA precur-
sors transit through CBs before their nuclear export. Part of the 
biological significance of this is confirmation that the precur-
sors are properly bound by PHAX. The results of this and other 
experiments imply the following model as to the major route of 
U snRNA transport from genes to cytoplasm (Fig. 6).
It was previously shown that actively transcribed U snRNA 
genes are frequently associated with CBs in mammalian cell   
nuclei and that the transcription by itself, i.e., the presence of 
Figure 3.  Effect of PHAX mutant proteins on 
the distribution of injected U snRNA precursors. 
(A) Schematic representation of the domain 
structures of human PHAX protein and the fea-
tures of the PHAX mutants used in this study. The 
numbers represent the amino acid numbers of 
the PHAX protein. WT, wild type. (B) The same 
mixture  of 
32P-labeled  RNAs  as  in  Fig.  2  A  
was injected into the nuclei of Xenopus oo-
cytes either alone (lanes 1–6) or together with 
25 ng/oocyte of recombinant PHAXCD (CD; 
lanes  7–9),  PHAXN  (N;  lanes  10–12), 
PHAXNES (NES; lanes 13–15), PHAXST2 
(ST2; lanes 16–18), WGA and CD (lanes 
19–21), WGA and N (lanes 22–24), WGA 
and NES (lanes 25–27), or WGA and ST2   
(lanes  28–30).  RNA  was  analyzed  as  in   
Fig. 2 A. (C and D) The ratio of the Nppt sig-
nal against the nuclear fraction total signal of 
U1Sm and U5Sm, respectively, was calcu-
lated from three independent experiments as 
in A. The means and standard deviations for 
WGA + CD, WGA + N, WGA + NES, 
and WGA + ST2 are shown. (E) The same 
RNA mixture was injected with either WGA + 
CD (lanes 1–9), WGA + N (lanes 10–18), 
or WGA + NES (lanes 19–27). RNA was an-
alyzed at 0, 1.5, and 3 h as in (A). (F) The dis-
tribution of Cy3-labeled m
7G-capped U1Sm 
RNA was analyzed as in Fig. 1 A at 2 h after 
microinjection in the presence of WGA + N 
(right) or WGA + CD (left). C, cytoplasmic 
fraction. Bars, 20 µm.609 Novel role for Cajal bodies in U snRNA export • Suzuki et al.
and Lamond, 2005). Therefore, it is likely that U snRNA pre-
cursors themselves move to CBs in Xenopus oocytes.
We do not have direct evidence that the binding of CBC 
is required for the entry of U snRNAs into CBs, mainly be-
cause of unavailability of strong inhibitory antibodies against 
CBC.  However,  we  do  have  supporting  evidence. A-capped   
U snRNA precursors, which do not bind CBC (Ohno et al., 
1990), did not accumulate in CBs after microinjection, unlike 
m
7G-capped counterparts (Fig. S1), suggesting that the m
7G-cap 
structure and probably also the binding of CBC to U snRNAs are 
important for the entry of U snRNAs into CBs. Moreover, our 
findings do not apparently support that the binding of PHAX is 
required for U snRNAs to enter CBs. The result that U snRNAs 
accumulated in CBs in the presence of the anti-PHAX antibody 
can be interpreted to mean that the antibody inhibited the exit 
from, but not the entry into, CBs. However, it is also possible 
that the antibody actually inhibits both the entry and exit to a 
certain extent but that its inhibitory effect on the exit is stronger 
for some reason. If so, U snRNAs should accumulate in CBs in 
the presence of the antibody. This is a mere assumption, but is 
consistent with the effect of the antibody being weaker than that 
of the PHAX N mutant.
structure of the nascent U snRNA transcript should first be-
come associated with CBC cotranscriptionally, and the com-
plex should then recruit PHAX, forming a trimeric complex 
of  U  snRNA,  CBC,  and  PHAX,  termed  the  precomplex  of 
U  snRNA  export  (Ohno  et  al.,  2000).  Because  PHAX  is   
enriched in CBs, this should result in the association of the 
U snRNA genes with CBs. This association may be assisted 
and/or stabilized by the nuclear actin system (Dundr et al., 
2007). Thus, when the U snRNA transcript is released from the 
gene into CBs, it is already in the form of the precomplex of 
U snRNA export. If this scenario is true, the binding of CBC 
to U snRNAs would be required for U snRNAs to accumu-
late in CBs. Moreover, the binding of PHAX to U snRNAs   
should  take  place  simultaneously  with  the  association  of   
U snRNAs with CBs, meaning that CBs are the major site for 
association of PHAX with U snRNAs. Our findings that the 
injected U snRNAs first accumulated in CBs may reflect part 
of this process. It is also likely that U snRNA precursors are 
sometimes transcribed away from CBs. Such transcripts may 
actually go first to CBs. It should be pointed out that there is 
no evidence that U snRNA genes are associated with CBs in 
amphibian oocytes (Abbott et al., 1999; for review see Cioce   
Figure 4.  Effect of CRM1 inhibition on the distribution of injected U snRNA precursors. (A) The same mixture of 
32P-labeled RNAs as in Fig. 2 A was 
injected into the nuclei of Xenopus oocytes either alone (lanes 1–6) or together with CD (lanes 7–9), N (lanes 10–12), 0.3 µg/oocyte BSAmut (lanes   
13–15), BSAmut + CD (lanes 16–18), BSAmut + N (lanes 19–21), 0.3 µg/oocyte BSA-NES (lanes 22–24), BSA-NES + CD (lanes 25–27), or   
BSA-NES + N (lanes 28–30). RNA was analyzed as in Fig. 2 A. (B and C) The ratio of the Nppt signal against the nuclear fraction total signal of   
U1Sm and U5Sm, respectively, was calculated from three independent experiments as in A. The means and standard deviations for BSA-NES alone, 
BSA-NES + CD, and BSA-NES + N are shown. C, cytoplasmic fraction.JCB • VOLUME 190 • NUMBER 4 • 2010   610
of such snoRNAs and U snRNAs may overlap at least partially. 
Is it then possible to find a unified mechanism for these two   
intranuclear transport systems? It was previously shown with 
mammalian cells that PHAX is required for the entry of micro-
injected U3 snoRNAs into CBs (Boulon et al., 2004). Consider-
ing the possibility that the binding of PHAX may also be required 
for U snRNAs to enter CBs in our system, our results do not 
necessarily contradict those of Boulon et al. (2004). Require-
ment of PHAX for the exit of U3 snoRNA from CBs is still open 
to question because the antibody inhibited the entry itself in their 
system (Boulon et al., 2004). In any case, because the majority 
of the transcription of both small RNAs takes place adjacent to 
CBs, the binding of these RNAs to PHAX may take place simul-
taneously with their association with CBs.
However, the requirement of CRM1 for the exit from CBs 
seems clearly different between the two systems. The binding of 
CRM1 is not required for U snRNAs to exit CBs in our system 
(Fig. 4). In contrast, Boulon et al. (2004) showed that CRM1 
is important for U3 snoRNAs to exit CBs in mammalian cells. 
This is a puzzling result because CRM1 is an export factor, and 
U3 snoRNAs are thought not to leave the nucleus. However,   
it should also be pointed out that some snoRNAs might actu-
ally leave the nucleus temporarily like U snRNAs (Watkins   
et al., 2007). If this is the case, the maturation pathways for   
U snRNAs and snoRNAs would be even more similar. More ex-
periments are required to establish a plausible unified model.
CBs, dynamic structures for accelerating 
maturation of small RNPs
CBs are dynamic nuclear subdomains involved in the biogene-
sis of several classes of small RNPs. In CBs, extensive internal 
modifications of the U snRNAs by 2’-O-methylation and pseudo-
uridylation, as well as specific assemblies of some U snRNPs, 
take place (for review see Stanek and Neugebauer, 2006).   
In this study, using the Xenopus oocyte system, we found an-
other function of CBs, surveillance of the export U snRNP as-
sembly. Our results also suggested that CBs are the major site 
for PHAX to associate with U snRNAs. Whether this is a general 
After their entry into CBs, U snRNAs can be released 
from the CBs into the nucleoplasm, provided that the pre-
complex is properly formed and maintained. However, if the 
binding of PHAX is affected for some reason, by the actions of 
a specific antibody for example, the U snRNAs cannot leave the 
CBs. Thus, we provide the first evidence that CBs function in 
the surveillance of the U snRNA preexport complex assembly. 
Regarding the actions of PHAX N, this mutant can bind to 
RNA but not stably to CBC (Segref et al., 2001), and therefore, 
the precomplex containing this mutant is likely to be abnormal. 
This abnormal precomplex may be functional for U snRNA entry 
into CBs but not for their exit. The requirements of the quality 
of the precomplex may be more strict for the exit than entry. 
This notion is also consistent with the assumption that the effect 
of the PHAX antibody is stronger for the exit. The molecular 
mechanism to retain U snRNAs without properly bound PHAX 
is totally unknown at the moment.
Another U snRNA export factor, CRM1, is also concen-
trated in CBs, but we could not provide evidence to show that its 
binding to the precomplex, i.e., the formation of the full export 
complex, is required for the exit of U snRNAs from CBs. In re-
lation to this, there is no evidence that RanGTP, the last known 
component  of  the  export  complex,  is  concentrated  in  CBs. 
Therefore, the binding of CRM1–RanGTP, i.e., the formation of 
the full export complex, may occur not in CBs but in the nucleo-
plasm. In any case, once the export complex is formed, it should 
be competent for passage through NPCs.
Comparison with intranuclear transport  
of snoRNAs
There are a group of small RNAs termed snoRNAs that finally 
accumulate in the nucleoli (for review see Matera et al., 2007).   
It is thought that a class of snoRNAs, including U3, also transit 
through CBs before going to the nucleolus after transcription, 
although snoRNAs are believed not to leave the nucleus, unlike 
U snRNAs (for review see Matera et al., 2007). Because some of 
the actively transcribed snoRNA genes are also associated with 
CBs (Gao et al., 1997; Jacobs et al., 1999), intranuclear transport 
Figure 5.  Effect of the inhibitors on the dis-
tribution  of  in  vivo–transcribed  U  snRNAs.   
A mixture of the plasmids harboring the U1Sm 
and  U2Sm  genes  was  microinjected  into 
the  nuclei  of  Xenopus  oocytes  either  alone 
(lanes 1–3) or together with control (ctr) IgG 
(lanes 4–6), anti-PHAX antibody (lanes 7–9), 
CD protein (lanes 10–12), N protein (lanes 
13–15), or NES protein (lanes 16–18), and 
the nucleocytoplasmic distribution of the tran-
scripts was analyzed by Northern blotting of 
the  Nsup,  Nppt,  and  cytoplasmic  (C)  RNA   
fractions  after  1.5  h.  Black  lines  indicate   
that intervening lanes have been spliced out. 
(B and C) The ratio of the Nppt signal against 
the nuclear fraction total signal of U1Sm   
and  U2Sm,  respectively,  was  calculated 
from three independent experiments as in A. 
The  means  and  the  standard  deviations  for 
WGA+ctr  IgG,  WGA+anti-PHAX  antibody, 
WGA+CD,  WGA+N,  and  WGA+NES 
are shown.611 Novel role for Cajal bodies in U snRNA export • Suzuki et al.
(Gall et al., 1991). The nuclei were collected in an Eppendorf tube, and iso-
lation medium was added to 150 µl. The sample was spun down in a 
microfuge at 15,000 rpm for 15 min at 4°C, and the soluble fraction was 
recovered. The insoluble fraction was washed once with 150 µl of isolation 
medium, and the soluble fraction was combined with the previous soluble 
fraction. RNA was isolated from Nsup, Nppt, and the cytoplasmic fraction 
by phenol extraction and ethanol precipitation. RNA was analyzed by 8% 
polyacrylamide/7 M urea gel electrophoresis. Analysis and quantitation 
of 
32P-labeled RNA bands were performed with BSA-2500 (Fujifilm) and 
Image Gauge (version 3.45; Fujifilm). Alternatively, RNA bands were visu-
alized by Northern blotting with specific probes.
Band shift assay
The band shift assay was performed as described previously (Ohno et al., 
2000). In short, 
32P-labeled m
7G-capped U1Sm was incubated with recom-
binant proteins in band shift buffer (40 mM Hepes KOH, pH 7.3, 110 mM   
KOAc, 6 mM Mg(OAc)2, 250 mM sucrose, and 0.8 mg/ml Escherichia coli 
tRNA) for 20 min at 25°C. The samples were fractionated by native 6% 
PAGE followed by autoradiography. Anti-PHAX antibody was affinity puri-
fied as described previously (Kitao et al., 2008).
Western and Northern blot analyses
Western blotting was performed as described previously (Kitao et al., 
2008) with a monoclonal anti-coilin antibody (Invitrogen), a monoclonal 
anti-U2B” antibody (Progen), and an affinity-purified anti-PHAX antibody 
(Kitao et al., 2008). Northern blotting was performed as described previ-
ously (Fuke and Ohno, 2008) with 5-CTTTCGAGCACATTTCACCAGG-3 
and 5-CCAACTCCCGGATCCCCGGAGCTTGCCATTTAATA-3 as probes 
for U3 snoRNA and U2Sm, respectively. The probes for 5.8S and U1Sm 
RNAs were as described previously (Fuke and Ohno, 2008).
Online supplemental material
Fig. S1 shows the effect of the m7G-cap structure on the distribution of   
injected U snRNA precursors. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201004109/DC1.
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